Stereotaxis, Inc. (FRA:RJR1)

Market Cap	172.03M -1.5%
Revenue (ttm)	25.63M +19.6%
Net Income	-21.23M
EPS	-0.24
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	128
Open	0.6710
Previous Close	0.6120
Day's Range	0.6710 - 0.6710
52-Week Range	0.6710 - 2.3600
Beta	n/a
RSI	45.47
Earnings Date	Mar 5, 2026

About Stereotaxis

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminat...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1990
• Employees: 139
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RJR1

Financial Performance

In 2024, Stereotaxis's revenue was $26.92 million, an increase of 0.55% compared to the previous year's $26.77 million. Losses were -$25.35 million, 14.9% more than in 2023.

Financial numbers in USD